» Articles » PMID: 35246513

SIRT6 Mediates MRTF-A Deacetylation in Vascular Endothelial Cells to Antagonize OxLDL-induced ICAM-1 Transcription

Overview
Date 2022 Mar 5
PMID 35246513
Authors
Affiliations
Soon will be listed here.
Abstract

Oxidized low-density lipoprotein (oxLDL), a known risk factor for atherosclerosis, activates the transcription of adhesion molecules (ICAM-1) in endothelial cells. We previously showed that myocardin-related transcription factor A (MRTF-A) mediates oxLDL-induced ICAM-1 transcription. Here we confirm that ICAM-1 transactivation paralleled dynamic alterations in MRTF-A acetylation. Since treatment with the antioxidant NAC dampened MRTF-A acetylation, MRTF-A acetylation appeared to be sensitive to cellular redox status. Of interest, silencing of SIRT6, a lysine deacetylase, restored MRTF-A acetylation despite the addition of NAC. SIRT6 directly interacted with MRTF-A to modulate MRTF-A acetylation. Deacetylation of MRTF-A by SIRT6 led to its nuclear expulsion thus dampening MRTF-A occupancy on the ICAM-1 promoter. Moreover, SIRT6 expression was downregulated with oxLDL stimulation likely owing to promoter hypermethylation in endothelial cells. DNA methyltransferase 1 (DNMT1) was recruited to the SIRT6 promoter and mediated SIRT6 repression. The ability of DNMT1 to repress SIRT6 promoter partly was dependent on ROS-sensitive serine 154 phosphorylation. In conclusion, our data unveil a novel DNMT1-SIRT6 axis that contributes to the regulation of MRTF-A acetylation and ICAM-1 transactivation in endothelial cells.

Citing Articles

Chromatin modifiers in human disease: from functional roles to regulatory mechanisms.

Nie Y, Song C, Huang H, Mao S, Ding K, Tang H Mol Biomed. 2024; 5(1):12.

PMID: 38584203 PMC: 10999406. DOI: 10.1186/s43556-024-00175-1.


Inhibition of SIRT6 aggravates p53-mediated ferroptosis in acute lung injury in mice.

Cao Y, Peng T, Ai C, Li Z, Lei X, Li G Heliyon. 2023; 9(11):e22272.

PMID: 38034611 PMC: 10685376. DOI: 10.1016/j.heliyon.2023.e22272.


SIRT6's function in controlling the metabolism of lipids and glucose in diabetic nephropathy.

Wang Y, Liu T, Cai Y, Liu W, Guo J Front Endocrinol (Lausanne). 2023; 14:1244705.

PMID: 37876546 PMC: 10591331. DOI: 10.3389/fendo.2023.1244705.


Sirtuin 6-A Key Regulator of Hepatic Lipid Metabolism and Liver Health.

Dong X Cells. 2023; 12(4).

PMID: 36831330 PMC: 9954390. DOI: 10.3390/cells12040663.


MRTF may be the missing link in a multiscale mechanobiology approach toward macrophage dysfunction in space.

An R Front Cell Dev Biol. 2022; 10:997365.

PMID: 36172272 PMC: 9510870. DOI: 10.3389/fcell.2022.997365.

References
1.
Benjamin E, Muntner P, Alonso A, Bittencourt M, Callaway C, Carson A . Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019; 139(10):e56-e528. DOI: 10.1161/CIR.0000000000000659. View

2.
Mannsverk J, Wilsgaard T, Mathiesen E, Lochen M, Rasmussen K, Thelle D . Trends in Modifiable Risk Factors Are Associated With Declining Incidence of Hospitalized and Nonhospitalized Acute Coronary Heart Disease in a Population. Circulation. 2015; 133(1):74-81. DOI: 10.1161/CIRCULATIONAHA.115.016960. View

3.
Libby P, Hansson G . From Focal Lipid Storage to Systemic Inflammation: JACC Review Topic of the Week. J Am Coll Cardiol. 2019; 74(12):1594-1607. PMC: 6910128. DOI: 10.1016/j.jacc.2019.07.061. View

4.
Weber C, Zernecke A, Libby P . The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol. 2008; 8(10):802-15. DOI: 10.1038/nri2415. View

5.
He P . Leucocyte/endothelium interactions and microvessel permeability: coupled or uncoupled?. Cardiovasc Res. 2010; 87(2):281-90. PMC: 2895544. DOI: 10.1093/cvr/cvq140. View